Sign in

    Theresa Vitelle

    Director and Equity Research Analyst at Scotiabank

    Theresa Vitelle is a Director and Equity Research Analyst at Scotiabank, specializing in coverage of North American midstream oil and gas companies. She closely follows firms such as Enbridge, TC Energy, Pembina Pipeline, Gibson Energy, and Keyera, producing highly regarded research and investment recommendations. Over her career, Vitelle has consistently delivered strong calls in the sector, frequently recognized for her rigorous analysis and sector insight, and her recommendations have been well received by institutional investors, maintaining a solid performance record in sector rankings. Theresa began her finance career in the early 2010s, holds a Chartered Financial Analyst (CFA) designation, and joined Scotiabank after progressing through progressively senior analyst roles with other major Canadian financial institutions.

    Theresa Vitelle's questions to ALNYLAM PHARMACEUTICALS (ALNY) leadership

    Theresa Vitelle's questions to ALNYLAM PHARMACEUTICALS (ALNY) leadership • Q4 2024

    Question

    Theresa Vitelle, on for Greg Harrison, asked about the expected revenue mix for vutrisiran (AMVUTTRA) between naive patients versus those switching from other therapies.

    Answer

    Chief Commercial Officer Tolga Tanguler stated that while the company provided ambitious guidance, it would not break down the specific mix. He noted that AMVUTTRA is well-positioned to be a first-line standard of care but also expects a good mix of naive patients and switches from stabilizers, with all elements incorporated into their financial guidance.

    Ask Fintool Equity Research AI